What's New to The Street... 📉 U.S. stocks end mixed as tech shares advance U.S. markets closed with mixed results, as the S&P 500 rose 0.4%, the Nasdaq gained 1.1%, and the Dow Jones Industrial Average slipped less than 0.1%. @vincemedia1 The session highlights diverging market performance as investors monitor technology stocks and broader market trends. What do you think will drive the next move in U.S. markets? Share your thoughts below👇🏻 👉🏻 Follow @NewToTheStreet for market updates, business insights, and investor news. #StockMarket #SP500 #Nasdaq #DowJones #Technology #Innovation #MarketNews #Businessupdate #Businessnews #Business #News #Newtothestreet

⚡ American Fusion Reports Texatron™ Development Progress @FusionAMFN (OTCQB: AMFN) reports upgrades to its pulsed-power equipment, four commercial proposals under negotiation, and scientific review of its Texatron™ technical report. These developments highlight the company’s ongoing technical work and commercial engagement in fusion energy. @vincemedia1 READ HERE👇🏻 bit.ly/AmericanFusionpressre… Watch the @NewToTheStreet interview here👇🏻 bit.ly/NTTS-AmericanFusionCh… Learn more at americanfusionenergy.com #americanfusion #amfn #otcqb #fusionenergy #cleanenergy #zeroemissions #energytechnology #advancedenergy #electrification #innovation #sustainability #investing #newtothestreet

Big Sky Industrial Targets Three Key Industrial Markets @BSIN_IR (NASDAQ: BSIN) is positioned across three key markets: industrial gases, carbon infrastructure, and energy production. This diversified approach gives the company exposure to multiple sectors supporting industrial development and energy infrastructure. @vincemedia1 Watch the @NewToTheStreet interview⬇️ bit.ly/NTTS-BigSkyIndustrial… Check them out at bigskyindustrialinc.com #bigskyindustrial #bsin #helium #industrialgases #carbonmanagement #energy #infrastructure #usenergy #innovation #investing #newtothestreet

BioVie Reports Significant Long COVID Symptom Improvements in Phase 2 Cl... youtu.be/NGbc21A1hns?si=vNmp… via @YouTube @BioVie_Pharma @Nasdaq @IPOMarketcom @ExploringBlock @NYSE @vincemedia1

💳 Stewards Partners With Rain to Expand Small Business Access to Capital @stewards_usa (NASDAQ: SWRD) is partnering with Rain to develop a business card designed to provide small businesses with recurring access to capital. The collaboration aims to address financing needs and support greater flexibility for businesses managing their growth. @vincemedia1 READ HERE👇🏻 bit.ly/stewardspressrelease Stay tuned for Stewards Inc. coming to New to The Street! 👉🏻 Follow @NewToTheStreet for the latest business, finance, and investor news. #stewardsinc #swrd #nasdaq #openingbell #privatecredit #realassets #fintech #investing #businessnews #newtothestreet

NeOnc Technologies Adds Banking Expertise to Its Board @NeOncTechInc (NASDAQ: NTHI) appointed Ali Alabedin, Head of Islamic Banking Group at First Abu Dhabi Bank, to its Board of Directors, effective October 9, 2026. His appointment brings senior banking leadership experience to the clinical-stage biopharmaceutical company as it continues its corporate development. @vincemedia1 READ HERE👇🏻👇🏻👇🏻 bit.ly/NeOncpressrelease Watch the full @NewToTheStreet interview here👇🏻👇🏻👇🏻 bit.ly/NTTS-NeOncBreaksThrou… Check them out at neonc.com #neOnctechnologies #quazar #investment #biotech #funding #cancer #research #innovation #businessupdate #businessnews #business #news #newtothestreet

Sagtec Global CEO Discusses Nasdaq IPO, SaaS Growth and Global Expansion youtu.be/KIj8X4IW9x4?si=SlgS… via @YouTube @SagtecGroup @NasdaqExchange @Nasdaq @IPOMarketcom @ExploringBlock

🧬 Lantern Pharma Highlights AI-Driven Cancer Research @LanternPharma (NASDAQ: LTRN) is presenting at the ThinkEquity Conference on October 15, 2026, highlighting its AI-driven precision oncology approach and clinical-stage drug development pipeline. The company continues to explore how artificial intelligence can help advance targeted cancer therapies. @vincemedia1 Visit ir.lanternpharma.com to learn more! READ HERE👇🏻 bit.ly/LanternPharmaPressrel… Check out the @NewToTheStreet interview👇🏻 bit.ly/NTTS-LanternPharmaCEO… #lanternpharma #biotechinnovation #AI #healthcare #innovation #businessupdate #businessnews #business #news #newtothestreet

🌏 New to The Street Expands Bloomberg Reach Across Southeast Asia @NewToTheStreet is expanding its global television presence with a new Southeast Asia broadcast on Bloomberg, adding more than 60 million homes to its international reach. @vincemedia1 Beginning October 3, the sponsored programming will feature executive interviews, public company profiles, and business content for audiences across Southeast Asia, expanding New to The Street’s existing Bloomberg distribution across the United States, Latin America, and MENA. Ready to put your company in the spotlight? Explore our media solutions at newtothestreet.com Subscribe now and stay ahead!👇🏻 bit.ly/NewToTheStreetTV Watch the Newsout Feature👇🏻 bit.ly/NewtoTheStreetExpands… 👉🏻 Follow @NewToTheStreet for market updates, earnings coverage, and investor insights. #newtothestreet #billboards #interviews #branding #marketing #media #investorrelations #businessgrowth #visibility #capitalmarkets

🧬 Acurx Initiates PATHFINDER Clinical Trial @acurxpharma (NASDAQ: ACXP) announced that the first patient has been enrolled in its PATHFINDER clinical trial evaluating ibezapolstat in patients with multiply-recurrent C. difficile infection. @vincemedia1 READ HERE👇🏻 bit.ly/ACURXpressrelease Watch the Newsout feature here👇🏻👇🏻👇🏻 bit.ly/NTTS-NEWSOUT-AcurxEnr… Watch the @NewToTheStreet interview here👇🏻👇🏻👇🏻 bit.ly/NTTSAcurxCEO-FDAOpens… 👉🏻 Learn more at acurxpharma.com 👉🏻Follow @NewToTheStreet for the latest in biotech, innovation, and business updates! #acurxpharmaceuticals #wellness #health #healthcare #cure #medicine #pharmacy #science #businessupdate #businessnews #business #news #newtothestreet

🧬 Medicus Pharma Refocuses SkinJect® Clinical Development @MedicusLtd (NASDAQ: MDCX) will focus future internally sponsored clinical development of SkinJect® on Gorlin syndrome patients with multiple basal cell carcinoma lesions, while concluding further development in sporadic and nodular basal cell carcinoma. @vincemedia1 READ HERE⬇️ bit.ly/MedicusPharmaPressRel… Watch the new @NewToTheStreet interview here⬇ bit.ly/NTSS-MedicusPharmaint… Learn more at medicuspharma.com #medicuspharma #mdcx #biotechnews #healthcare #investorrelations #innovation #marketnews #newtothestreet

What's New to The Street... 📈 Nvidia expands share-repurchase program NVIDIA Corporation (NASDAQ: NVDA) has approved a $150 billion increase to its share-repurchase authorization, bringing the company’s total buyback authorization to $235 billion. @vincemedia1 The move highlights Nvidia’s continued focus on capital allocation as demand for AI infrastructure and accelerated computing remains a key area of its business. What could the expanded buyback program mean for Nvidia and its shareholders? Share your thoughts below👇🏻 👉🏻 Follow @NewToTheStreet for market updates, business insights, and investor news. #Nvidia #NVDA #AI #ArtificialIntelligence #Semiconductors #StockMarket #Innovation #MarketNews #Businessupdate #Businessnews #Business #News #Newtothestreet

Virtuix Expands Autism Therapy Program @VirtuixOmni (NASDAQ: VTIX) is expanding its autism therapy program through a new partnership and a multi-site pilot scheduled to begin in January 2027, further exploring applications for its immersive Omni One technology in therapeutic settings. @vincemedia1 Read the full press release⬇️ bit.ly/VirtuixPressrelease Watch the @NewToTheStreet new interview here⬇️ bit.ly/NTTS-VirtuixCEOReveal… Learn more at investors.virtuix.com #virtuix #vtix #virtualreality #gamingtech #vrtechnology #investornews #newtothestreet

🧠 NRx Advances Clinical Development With FDA Breakthrough Designation @NRxPharma (NASDAQ: NRXP) is advancing its clinical development programs through FDA clinical trials. Following results from the STABIL-B Phase 2 study, presented at ACNP in 2018, the FDA granted NRX-101 Breakthrough Therapy Designation. @vincemedia1 Watch the @NewToTheStreet interview here👇🏻 bit.ly/NTTS-NRXPharmaAdvance… 👉🏻Learn more at bit.ly/NRXPharmaceuticals #NRX #pharma #healthcare #biotechnews #innovation #businessupdate #businessnews #business #news #newtothestreet